BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18435965)

  • 1. Effect of successful alcohol septal ablation on microvascular function in patients with obstructive hypertrophic cardiomyopathy.
    Soliman OI; Geleijnse ML; Michels M; Dijkmans PA; Nemes A; van Dalen BM; Vletter WB; Serruys PW; ten Cate FJ
    Am J Cardiol; 2008 May; 101(9):1321-7. PubMed ID: 18435965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effects of alcohol septal ablation on systolic and diastolic left ventricular function in patients with hypertrophic obstructive cardiomyopathy.
    Steendijk P; Meliga E; Valgimigli M; Ten Cate FJ; Serruys PW
    Heart; 2008 Oct; 94(10):1318-22. PubMed ID: 18450844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained improvement in left ventricular diastolic function after alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
    Jassal DS; Neilan TG; Fifer MA; Palacios IF; Lowry PA; Vlahakes GJ; Picard MH; Yoerger DM
    Eur Heart J; 2006 Aug; 27(15):1805-10. PubMed ID: 16774986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of percutaneous transluminal septal myocardial ablation for obstructive hypertrophic cardiomyopathy on systolic and diastolic left ventricular function assessed by pressure-volume loops.
    Meliga E; Steendijk P; Valgimigli M; Ten Cate FJ; Serruys PW
    Am J Cardiol; 2008 Apr; 101(8):1179-84. PubMed ID: 18394455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of intravascular and extravascular mechanisms of myocardial perfusion abnormalities in obstructive hypertrophic cardiomyopathy by myocardial contrast echocardiography.
    Soliman OI; Knaapen P; Geleijnse ML; Dijkmans PA; Anwar AM; Nemes A; Michels M; Vletter WB; Lammertsma AA; ten Cate FJ
    Heart; 2007 Oct; 93(10):1204-12. PubMed ID: 17488767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of left ventricular diastolic function in obstructive hypertrophic cardiomyopathy in patients undergoing percutaneous septal alcohol ablation versus surgical myotomy/myectomy.
    Sitges M; Shiota T; Lever HM; Qin JX; Bauer F; Drinko JK; Agler DA; Martin MG; Greenberg NL; Smedira NG; Lytle BW; Tuzcu EM; Garcia MJ; Thomas JD
    Am J Cardiol; 2003 Apr; 91(7):817-21. PubMed ID: 12667567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of alcohol septal ablation for hypertrophic obstructive cardiomyopathy on Doppler Tei index: a midterm follow-up.
    Veselka J; Procházková S; Bolomová-Homolová I; Duchonová R; Tesar D
    Echocardiography; 2005 Feb; 22(2):105-9. PubMed ID: 15693775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non-pharmacologic therapy of hypertrophic obstructive cardiomyopathy--results of therapy based on percutaneous transluminal septal myocardial ablation compared with results of dual-chamber cardiac pacing].
    Krejcí J; Groch L; Meluzín J; Vykypel T; Halámek J; Vitovec J
    Vnitr Lek; 2006 Apr; 52(4):313-20. PubMed ID: 16755987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immediate improvement in coronary flow reserve after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.
    Jaber WA; Yang EH; Nishimura RA; Sorajja P; Rihal CS; Elesber A; Eeckhout E; Lerman A
    Heart; 2009 Apr; 95(7):564-9. PubMed ID: 18952634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of percutaneous transluminal septal myocardial ablation versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy--a meta analysis.
    Zeng Z; Wang F; Dou X; Zhang S; Pu J
    Int J Cardiol; 2006 Sep; 112(1):80-4. PubMed ID: 16507323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Doppler echocardiographic evaluation of left ventricular diastolic function in patients with hypertrophic obstructive cardiomyopathy after alcohol septal ablation in acute and long-term follow up].
    Wojtarowicz A; Kornacewicz-Jach Z; Kaźmierczak J; Szamlewski P; Gil R; Lewandowski M
    Pol Merkur Lekarski; 2002 Jul; 13(73):25-8. PubMed ID: 12362500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of septal ablation on regional diastolic dysfunction and diastolic asynchrony in patients with hypertrophic obstructive cardiomyopathy: a follow-up study using speckle tracking echocardiography.
    Chen S; Duan F; Yuan J; Qiao S; Lv X; Hu F; Yang W; Zhang J; Yang Y
    Echocardiography; 2013 May; 30(5):564-71. PubMed ID: 23305549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early remodelling of left ventricle and improvement of myocardial performance in patients after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.
    Veselka J; Honek T
    Int J Cardiol; 2003 Mar; 88(1):27-32. PubMed ID: 12659981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial evaluations of myocardial infarct size after alcohol septal ablation in hypertrophic cardiomyopathy and effects of the changes on clinical status and left ventricular outflow pressure gradients.
    Aqel RA; Hage FG; Zohgbi GJ; Tabereaux PB; Lawson D; Heo J; Perry G; Epstein AE; Dell' Italia LJ; Iskandrian AE
    Am J Cardiol; 2008 May; 101(9):1328-33. PubMed ID: 18435966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peak systolic longitudinal strain of the lateral left ventricular wall improves after septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: a follow-up study using speckle tracking echocardiography.
    Faber L; Prinz C; Welge D; Hering D; Butz T; Oldenburg O; Bogunovic N; Horstkotte D
    Int J Cardiovasc Imaging; 2011 Mar; 27(3):325-33. PubMed ID: 20694748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy.
    Seggewiss H; Faber L; Gleichmann U
    Thorac Cardiovasc Surg; 1999 Apr; 47(2):94-100. PubMed ID: 10363608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy.
    Seggewiss H; Rigopoulos A; Welge D; Ziemssen P; Faber L
    Clin Res Cardiol; 2007 Dec; 96(12):856-63. PubMed ID: 17891517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Percutaneous transluminal septal myocardial ablation: early results and long-term follow-up].
    Tekieli Ł; Pieniazek P; Podolec P; Tomkiewicz-Pajak L; Płazak W; Musiałek P; Leśniak-Sobelga A; Przewłocki T; Biernacka B; Zmudka K; Tracz W
    Przegl Lek; 2006; 63(8):628-32. PubMed ID: 17441371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biventricular reverse remodeling after successful alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Chen YZ; Qiao SB; Hu FH; Yuan JS; Yang WX; Cui JG; Zhang Y; Zhou Y; Zhang CL
    Am J Cardiol; 2015 Feb; 115(4):493-8. PubMed ID: 25541323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of alcohol septal ablation on coronary microvascular function and myocardial energetics in hypertrophic obstructive cardiomyopathy.
    Timmer SA; Knaapen P; Germans T; Dijkmans PA; Lubberink M; Ten Berg JM; Ten Cate FJ; Rüssel IK; Götte MJ; Lammertsma AA; van Rossum AC
    Am J Physiol Heart Circ Physiol; 2011 Jul; 301(1):H129-37. PubMed ID: 21490327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.